Abattis Bioceuticals

Abattis Bioceuticals (CSE:ATT)

Abattis Bioceuticals is a vertically integrated biotechnology company focused on natural health products, including cannabis. The company develops natural health products and conducts research and development for the pharmaceutical, nutraceutical, bioceutical and cosmetic markets.

In April 2017, the company announced it had signed an exclusive distribution agreement for proprietary extraction technology.